Maria Bartel

Maria Bartel

Auto-generated profile, based on publicly available information

Maria Bartel

Department of Chemistry, University of Duisburg-Essen, Universitätsstrasse 7, 45141, Essen, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2013 in Nature Chemistry
Verified
Journal Article
Closed access
DBDavid Bier
David Bier
RRRolf Rose
Rolf Rose
KBKenny Bravo-Rodriguez
Kenny Bravo-Rodriguez
MBMaria Bartel
Maria Bartel
JRJuan Manuel Ramirez-Anguita
Juan Manuel Ramirez-Anguita
COChristian Ottmann
Christian Ottmann

1 April 2013 in Chemistry & Biology
Verified
Journal Article
Closed access
CACarolin Anders
Carolin Anders
YHYusuke Higuchi
Yusuke Higuchi
KKKristin Koschinsky
Kristin Koschinsky
MBMaria Bartel
Maria Bartel
BSBenjamin Schumacher
Benjamin Schumacher
COChristian Ottmann
Christian Ottmann

23 June 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YJYuyoung Joo
Yuyoung Joo
BSBenjamin Schumacher
Benjamin Schumacher
ILIsabelle Landrieu
Isabelle Landrieu
MBMaria Bartel
Maria Bartel
CSCaroline Smet‐Nocca
Caroline Smet‐Nocca
YSYoo‐Hun Suh
Yoo‐Hun Suh
14‐3‐3 proteins act as adapters that exert their function by interacting with their various protein partners. 14‐3‐3 proteins have been implicated in a variety of human diseases including neurodegenerative diseases. 14‐3‐3 proteins have recently been reported to be abundant in the neurofibrillary tangles (NFTs) observed inside the neurons of brains affected by Alzheimer's disease (AD). These NFTs are mainly constituted of phosphorylated Tau protein, a microtubule‐associated protein known to bind 14‐3‐3. Despite this indication of 14‐3‐3 protein involvement in the AD pathogenesis, the role of 14‐3‐3 in the Tauopathy remains to be clarified. In the present study, we shed light on the role of 14‐3‐3 proteins in the molecular pathways leading to Tauopathies. Overexpression of the 14‐3‐3ct isoform resulted in a disruption of the tubulin cytoskeleton and prevented neuritic outgrowth in neurons. NMR studies validated the phosphorylated residues pSer214 and pSer324 in Tau as the 2 primary sites for 14‐3‐3 binding, with the crystal structure of 14‐3‐3σ in complex with Tau‐pSer214 and Tau‐pSer324 revealing the molecular details of the interaction. These data suggest a rationale for a possible pharmacologic intervention of the Tau/14‐3‐3 interaction.—Joo, Y., Schumacher, B., Landrieu, I., Bartel, M., Smet‐Nocca, C., Jang, A., Choi, H. S., Jeon, N. L., Chang, K.‐A, Kim, H.‐S., Ottmann, C., Suh, Y.‐H. Involvement of 14‐3‐3 in tubulin instability and impaired axon development is mediated by Tau. FASEB J. 29, 4133‐4144 (2015). www.fasebj.org

5 November 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LMLech‐Gustav Milroy
Lech‐Gustav Milroy
MBMaria Bartel
Maria Bartel
MHMorkos A. Henen
Morkos A. Henen
SLSeppe Leysen
Seppe Leysen
JAJoris M. C. Adriaans
Joris M. C. Adriaans
COChristian Ottmann
Christian Ottmann

2 November 2017 in Journal of the American Chemical Society
Verified
Journal Article
Open access
DBDavid Bier
David Bier
SMSumit Mittal
Sumit Mittal
KBKenny Bravo-Rodriguez
Kenny Bravo-Rodriguez
ASAndrea Sowislok
Andrea Sowislok
XGXavier Guillory
Xavier Guillory
COChristian Ottmann
Christian Ottmann
Protein regions that are involved in protein–protein interactions (PPIs) very often display a high degree of intrinsic disorder, which is reduced during the recognition process. A prime example is binding of the rigid 14-3-3 adapter proteins to their numerous partner proteins, whose recognition motifs undergo an extensive disorder-to-order transition. In this context, it is highly desirable to control this entropy-costly process using tailored stabilizing agents. This study reveals how the molecular tweezer CLR01 tunes the 14-3-3/Cdc25CpS216 protein–protein interaction. Protein crystallography, biophysical affinity determination and biomolecular simulations unanimously deliver a remarkable finding: a supramolecular “Janus” ligand can bind simultaneously to a flexible peptidic PPI recognition motif and to a well-structured adapter protein. This binding fills a gap in the protein–protein interface, “freezes” one of the conformational states of the intrinsically disordered Cdc25C protein partner and enhances the apparent affinity of the interaction. This is the first structural and functional proof of a supramolecular ligand targeting a PPI interface and stabilizing the binding of an intrinsically disordered recognition motif to a rigid partner protein.

8 December 2015 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
DBDavid Bier
David Bier
MBMaria Bartel
Maria Bartel
KSKatharina Sies
Katharina Sies
SHSebastian Halbach
Sebastian Halbach
YHYusuke Higuchi
Yusuke Higuchi
COChristian Ottmann
Christian Ottmann